UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Vascular comorbidities in the onset and progression of multiple sclerosis

Journal of the neurological sciences, 2014-12, Vol.347 (1), p.23-33

2014

Volltextzugriff (PDF)

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis

Journal of neurology, 2009-04, Vol.256 (4), p.577-585

2009

Volltextzugriff (PDF)

Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data

Journal of neurology, neurosurgery and psychiatry, 2018-11, Vol.89 (11), p.1200-1207

2018

Volltextzugriff (PDF)

Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016

Journal of neurology, neurosurgery and psychiatry, 2018-01, Vol.89 (1), p.34-41

2018

Volltextzugriff (PDF)

The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology

Journal of the neurological sciences, 2015-01, Vol.348 (1), p.126-131

2015

Volltextzugriff (PDF)

Latitudinal variation in incidence and type of first central nervous system demyelinating events

Multiple sclerosis, 2010-04, Vol.16 (4), p.398-405

2010

Volltextzugriff (PDF)

Human leukocyte antigen-DR15, low infant sibling exposure and multiple sclerosis: Gene-environment interaction

Annals of neurology, 2010-02, Vol.67 (2), p.261-265

2010

Volltextzugriff (PDF)

What affects your MS? Responses to an anonymous, Internet-based epidemiological survey

Multiple sclerosis, 2004-04, Vol.10 (2), p.202-211

2004

Volltextzugriff (PDF)

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

Journal of neurology, neurosurgery and psychiatry, 2011-10, Vol.82 (10), p.1132-1141

2011

Volltextzugriff (PDF)

Genetic Dissection of the Human Leukocyte Antigen Region by Use of Haplotypes of Tasmanians with Multiple Sclerosis

American journal of human genetics, 2002-05, Vol.70 (5), p.1125-1137

2002

Volltextzugriff (PDF)

CTLA-4 and multiple sclerosis: The A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population

Journal of neuroimmunology, 2008-05, Vol.196 (1), p.139-142

2008

Volltextzugriff (PDF)

Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis

Journal of neurology, 2021-02, Vol.268 (2), p.602-612

2021

Volltextzugriff (PDF)

Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS

Neurology, 2012-07, Vol.79 (3), p.254-260

2012

Volltextzugriff (PDF)

Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms

Journal of neurology, 2021-02, Vol.268 (2), p.559-568

2021

Volltextzugriff (PDF)

Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis

Journal of neurology, 2021-02, Vol.268 (2), p.569-581

2021

Volltextzugriff (PDF)

Protocol for a pragmatic randomised controlled feasibility study of MS WorkSmart: an online intervention for Australians with MS who are employed

BMJ open, 2024-05, Vol.14 (5), p.e079644

2024

Volltextzugriff (PDF)

The impact of multiple sclerosis severity on health state utility values: Evidence from Australia

Multiple sclerosis, 2017-07, Vol.23 (8), p.1157-1166

2017

Volltextzugriff (PDF)

Adverse lipid profile is not associated with relapse risk in MS: Results from an observational cohort study

Journal of the neurological sciences, 2014-05, Vol.340 (1), p.230-232

2014

Volltextzugriff (PDF)

Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis

Multiple sclerosis, 2012-06, Vol.18 (6), p.799-806

2012

Volltextzugriff (PDF)

Higher Non-processed Red Meat Consumption Is Associated With a Reduced Risk of Central Nervous System Demyelination

Frontiers in neurology, 2019-02, Vol.10, p.125-125

2019

Volltextzugriff (PDF)

Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset

Frontiers in neurology, 2018-06, Vol.9, p.418-418

2018

Volltextzugriff (PDF)

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis

Annals of neurology, 2010-08, Vol.68 (2), p.193-203

2010

Volltextzugriff (PDF)

Association between human herpesvirus & human endogenous retrovirus and MS onset & progression

Journal of the neurological sciences, 2017-01, Vol.372, p.239-249

2017

Volltextzugriff (PDF)

Vitamin D and multiple sclerosis

Journal of clinical neuroscience, 2013-05, Vol.20 (5), p.634-641

2013

Volltextzugriff (PDF)

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

Journal of neurology, 2024-01, Vol.271 (1), p.472-485

2024

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

ThemaNeurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Vascular comorbidities in the onset and progression of multiple sclerosis

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis

Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data

Complementary and alternative treatments of multiple sclerosis: a review of the evidence from 2001 to 2016

The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology

Latitudinal variation in incidence and type of first central nervous system demyelinating events

Human leukocyte antigen-DR15, low infant sibling exposure and multiple sclerosis: Gene-environment interaction

What affects your MS? Responses to an anonymous, Internet-based epidemiological survey

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

Genetic Dissection of the Human Leukocyte Antigen Region by Use of Haplotypes of Tasmanians with Multiple Sclerosis

CTLA-4 and multiple sclerosis: The A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population

Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis

Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS

Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms

Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis

Protocol for a pragmatic randomised controlled feasibility study of MS WorkSmart: an online intervention for Australians with MS who are employed

The impact of multiple sclerosis severity on health state utility values: Evidence from Australia

Adverse lipid profile is not associated with relapse risk in MS: Results from an observational cohort study

Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis

Higher Non-processed Red Meat Consumption Is Associated With a Reduced Risk of Central Nervous System Demyelination

Onset Symptoms, Tobacco Smoking, and Progressive-Onset Phenotype Are Associated With a Delayed Onset of Multiple Sclerosis, and Marijuana Use With an Earlier Onset

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis

Association between human herpesvirus & human endogenous retrovirus and MS onset & progression

Vitamin D and multiple sclerosis

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies

Aktive Filter

Suchergebnisse filtern